XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue- Gilead Science Inc (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 7 Months Ended
Oct. 14, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Jul. 31, 2022
Dec. 31, 2022
Collaboration And Other Agreements [Line Items]              
Revenues   $ 13,136 $ 26,007 $ 37,632 $ 37,108    
Deferred revenue, current   9,671   9,671     $ 9,988
Deferred revenue, net of current portion   58,538   58,538     59,480
Gilead | 2022 Gilead Collaboration And License Agreement              
Collaboration And Other Agreements [Line Items]              
Non-refundable upfront payment           $ 60,000  
Revenues   200   600      
Deferred revenue   59,200   59,200     59,800
Deferred revenue, current   $ 2,200   $ 2,200     1,800
Deferred revenue, net of current portion     $ 57,000   $ 57,000   $ 58,000
Potential target nomination, option fees and milestone payments $ 1,700,000